De-Pei Wu

Featured in: Favicon

Articles

Hematopoietic stem cell transplantation activity in China 2022-2023. The proportions of peripheral blood for stem cell source continue to grow: a report from the Chinese Blood and Marrow Transplantation Registry Group | Bone Marrow Transplantation

Sep 24, 2024 | nature.com | Lan-Ping Xu |De-Pei Wu |He Huang |Dai-Hong Liu |Xi Zhang |Xiao-Yu Zhu | +4 more

AbstractOver past two years, a total of 39,918 hematopoietic stem cell transplantation (HSCT) cases were reported, with 18,194 and 21,714 transplants performed in 2022 and 2023, respectively. Autologous HSCT accounted for 6562 cases (31%) in 2022, while allogeneic HSCT comprised 12,632 cases (69%). In 2023, the number of allogeneic HSCTs exceeded 15,000, maintaining a 69% share.
Improved prevention and treatment strategies for differentiation syndrome contribute to reducing early mortality in patients with acute promyelocytic leukemia | Blood Cancer Journal

Jul 14, 2024 | nature.com | Qian Wu |Weiying Gu |De-Pei Wu

To the Editor,With the introduction of differentiating agents, such as all-trans retinoic acid (ATRA) and arsenic trioxide (ATO), the outcomes of patients with acute promyelocytic leukemia (APL) have significantly improved [1, 2]. However, there are still many early deaths, especially among those at high risk [3, 4]. In our retrospective study of 570 patients with APL, early mortality was 7.54% [5].

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.